Clinical Trials Browser

Phase 2 × Gastro Intestinal Stromal Tumor × masitinib × Clear all

NCT01506336 2018-12-11

Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib

Phase 2 Completed

Gastro Intestinal Stromal Tumor